EV/EBITDA
-0.53
0.000.00%
Fri, 29 Nov 2024 21:15:42 GMT
Summary:
BioNexus Gene Lab EV/EBITDA is currently -0.53, unchanged from the previous trading day. Over the past year, it has increased by +5.07 (+90.54%). BGLC EV/EBITDA is now -100.47% below its all-time high of 113.05.BGLC EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BGLC EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | 0.0% |
| 1 m1 month | +86.2% |
| 3 m3 months | +61.6% |
| 6 m6 months | +49.5% |
| ytdytd | +62.1% |
| 1 y1 year | +90.5% |
| 5 y5 years | - |
BGLC EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -0.46 | -15.2% | -3.84 | +86.2% |
| 3 m | 3 months | -0.46 | -15.2% | -5.34 | +90.1% |
| 6 m | 6 months | -0.46 | -15.2% | -5.34 | +90.1% |
| 1 y | 1 year | -0.46 | -15.2% | -5.60 | +90.5% |
| 3 y | 3 years | 113.05 | -100.5% | -206.21 | +99.7% |
| 5 y | 5 years | 113.05 | -100.5% | -206.21 | +99.7% |
| alltime | all time | 113.05 | -100.5% | -206.21 | +99.7% |
BioNexus Gene Lab EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -0.53(-62.1%) |
| 2023 | -1.40(-97.8%) |
| Date | Value |
|---|---|
| 2022 | -62.92(-358.4%) |
| 2021 | 24.35 |
FAQ
- What is BioNexus Gene Lab EV/EBITDA?
- What is the all time high EV/EBITDA for BioNexus Gene Lab?
- What is BGLC EV/EBITDA year-to-date change?
- What is BioNexus Gene Lab EV/EBITDA year-on-year change?
What is BioNexus Gene Lab EV/EBITDA?
The current EV/EBITDA of BGLC is -0.53
What is the all time high EV/EBITDA for BioNexus Gene Lab?
BioNexus Gene Lab all-time high EV/EBITDA is 113.05
What is BGLC EV/EBITDA year-to-date change?
BioNexus Gene Lab EV/EBITDA has changed by +0.87 (+62.14%) since the beginning of the year
What is BioNexus Gene Lab EV/EBITDA year-on-year change?
Over the past year, BGLC EV/EBITDA has changed by +5.07 (+90.54%)